ARKG
$30.38ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense ratio
0.75%
Dividend yield
0.00%
AUM
$1.24B
Issuer
ARK
YTD return
7.21%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · ARKG
| TEM | Tempus AI Inc Class A common stock | 9.45% |
| TWST | Twist Bioscience Corp | 9.02% |
| CRSP | CRISPR Therapeutics AG | 8.94% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.78% |
| BEAM | Beam Therapeutics Inc | 5.44% |
| ABSI | Absci Corp | 4.79% |
| NTRA | Natera Inc | 4.08% |
| ILMN | Illumina Inc | 4.04% |
| NTLA | Intellia Therapeutics Inc | 3.83% |
| PSNL | Personalis Inc | 3.59% |
Sector exposure
Sector breakdown · ARKG
Healthcare100.0%